Both in Surgical Instruments
GLOBUS MEDICAL vs Haemonetics
Over the past year GMED returned +27.5% and HAE returned +138.0%; their daily moves had a correlation of 0.20.
GMED +27.5% HAE +138.0%Growth of $1, one year, split-adjusted
| Metric | GMED | HAE |
|---|---|---|
| Price | $78.05 | $119.65 |
| Market cap | $10.48B | $5.44B |
| Today | −5.86% | −0.12% |
| 1 month | +4.9% | +14.6% |
| 6 months | −14.6% | +101.9% |
| Year to date | −10.6% | +49.3% |
| 1 year | +27.0% | +142.0% |
| Revenue growth (YoY) | +5.9% | +5.6% |
| Gross margin | 69.4% | 59.8% |
| Net margin | 19.2% | 9.7% |
| P/E (TTM) | 19.6× | 56.5× |
| Price / sales | 3.3× | 4.0× |
| Net cash | $595.1M | -$950.8M |
| Dividend yield | — | — |
| Volatility (60d) | 31.1% | 49.0% |
| Short % of float | 6.2% | 7.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).